AU2968892A - Vaccines based on modified type 1 bovine herpesviruses - Google Patents

Vaccines based on modified type 1 bovine herpesviruses

Info

Publication number
AU2968892A
AU2968892A AU29688/92A AU2968892A AU2968892A AU 2968892 A AU2968892 A AU 2968892A AU 29688/92 A AU29688/92 A AU 29688/92A AU 2968892 A AU2968892 A AU 2968892A AU 2968892 A AU2968892 A AU 2968892A
Authority
AU
Australia
Prior art keywords
modified type
vaccines based
bovine herpesviruses
herpesviruses
bovine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU29688/92A
Other versions
AU660741B2 (en
Inventor
Georg Floss
Gunther Keil
Walter Strube
Peter Thein
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer AG
Original Assignee
Bayer AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer AG filed Critical Bayer AG
Publication of AU2968892A publication Critical patent/AU2968892A/en
Application granted granted Critical
Publication of AU660741B2 publication Critical patent/AU660741B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2/00—Peptides of undefined number of amino acids; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
    • C12N2710/16721—Viruses as such, e.g. new isolates, mutants or their genomic sequences
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
    • C12N2710/16722—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biotechnology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Communicable Diseases (AREA)
  • Biophysics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AU29688/92A 1991-12-16 1992-11-26 Vaccines based on modified type 1 bovine herpesviruses Ceased AU660741B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4141400A DE4141400A1 (en) 1991-12-16 1991-12-16 Vaccines based on modified Bovine herpes viruses type 1
DE4141400 1991-12-16

Publications (2)

Publication Number Publication Date
AU2968892A true AU2968892A (en) 1993-07-01
AU660741B2 AU660741B2 (en) 1995-07-06

Family

ID=6447143

Family Applications (1)

Application Number Title Priority Date Filing Date
AU29688/92A Ceased AU660741B2 (en) 1991-12-16 1992-11-26 Vaccines based on modified type 1 bovine herpesviruses

Country Status (13)

Country Link
EP (1) EP0547446B1 (en)
JP (1) JPH05276942A (en)
KR (1) KR100265717B1 (en)
AR (1) AR248047A1 (en)
AT (1) ATE165620T1 (en)
AU (1) AU660741B2 (en)
CA (1) CA2085191C (en)
DE (2) DE4141400A1 (en)
DK (1) DK0547446T3 (en)
ES (1) ES2116306T3 (en)
HU (2) HU215537B (en)
MX (1) MX9206973A (en)
ZA (1) ZA929719B (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5783195A (en) * 1991-07-18 1998-07-21 Syntro Corporation Recombinant infectious bovine rhinotracheitis virus S-IBR-052 and uses thereof
US6410033B1 (en) 1987-07-27 2002-06-25 Syntro Corporation Recombinant infectious bovine rhinotracheitis virus
NL9100989A (en) * 1991-06-07 1993-01-04 Stichting Centr Diergeneeskund BOVINE HERPESVIRUS TYPE 1 DELETION MUTANTS, VACCINES BASED ON THESE, DIAGNOSTIC KITS FOR DETECTION OF BOVINE HERPESVIRUS TYPE 1.
CA2136381A1 (en) * 1993-11-23 1995-05-24 Gunther Keil Vector vaccines of bovine herpesvirus 1
EP0663403A1 (en) * 1993-11-23 1995-07-19 Akzo Nobel N.V. Vector vaccines of bovine herpesvirus I

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4992051A (en) * 1987-11-03 1991-02-12 Novagene, Inc. Infectious bovine rhinotracheitis virus mutants, methods for the production of same and methods for the use of same
NL9100989A (en) * 1991-06-07 1993-01-04 Stichting Centr Diergeneeskund BOVINE HERPESVIRUS TYPE 1 DELETION MUTANTS, VACCINES BASED ON THESE, DIAGNOSTIC KITS FOR DETECTION OF BOVINE HERPESVIRUS TYPE 1.

Also Published As

Publication number Publication date
HU215537B (en) 1999-01-28
EP0547446A2 (en) 1993-06-23
DE59209310D1 (en) 1998-06-04
AU660741B2 (en) 1995-07-06
KR100265717B1 (en) 2000-09-15
ZA929719B (en) 1993-06-14
HUT65487A (en) 1994-06-28
CA2085191A1 (en) 1993-06-17
DE4141400A1 (en) 1993-06-17
EP0547446B1 (en) 1998-04-29
DK0547446T3 (en) 1998-12-07
AR248047A1 (en) 1995-05-31
KR930012826A (en) 1993-07-21
CA2085191C (en) 2003-11-04
MX9206973A (en) 1993-06-01
ATE165620T1 (en) 1998-05-15
JPH05276942A (en) 1993-10-26
EP0547446A3 (en) 1994-09-28
ES2116306T3 (en) 1998-07-16
HU9203976D0 (en) 1993-03-29

Similar Documents

Publication Publication Date Title
HU9200850D0 (en) Medicative aerosoles
ZA947828B (en) Vaccines
AU3247093A (en) Flea midgut-supernatant vaccines
AU654362B2 (en) Pyrrolopyrazines
AU2752292A (en) Humidifier
AU9137791A (en) Imidazolyl-alkenoic acids
AU1556892A (en) 2-substituted-2-imidazolines
GB9325496D0 (en) Vaccines
AU2850492A (en) Novel aminoalkanephosphinic acids and salts thereof
AU1080292A (en) Ige-receptor-antibodies
AU6715094A (en) Recombinant vaccine
AU2968892A (en) Vaccines based on modified type 1 bovine herpesviruses
AU640328B2 (en) Sulfimidoperoxycarboxylic acids
AU1270592A (en) Modified interleukin-1beta
AU1209092A (en) Articulator
ZA948685B (en) Vaccines
AU3048689A (en) Immunogenic peptides
AU2880792A (en) Chair
ZA948729B (en) Vaccines
AU1588892A (en) Watch-strap
AU6409894A (en) Recognin vaccines
RU2003840C1 (en) Fan
AU1851392A (en) Ccv vaccine
AU1581092A (en) Nystagmograph
AU1015192A (en) (s)-11-hydroxy-10-methylaporphine